SpeeDx Pty Ltd Revenue and Competitors
Estimated Revenue & Valuation
- SpeeDx Pty Ltd's estimated annual revenue is currently $21.2M per year.
- SpeeDx Pty Ltd's estimated revenue per employee is $155,000
- SpeeDx Pty Ltd's total funding is $33.8M.
Employee Data
- SpeeDx Pty Ltd has 137 Employees.
- SpeeDx Pty Ltd grew their employee count by -4% last year.
SpeeDx Pty Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Information Communication Technology Specialist | Reveal Email/Phone |
SpeeDx Pty Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $52.4M | 338 | 28% | N/A | N/A |
#2 | $13.8M | 89 | 9% | N/A | N/A |
#3 | $18.6M | 120 | 21% | N/A | N/A |
#4 | $17.1M | 110 | -1% | N/A | N/A |
#5 | $48.1M | 310 | 6% | N/A | N/A |
#6 | $15.3M | 99 | 27% | N/A | N/A |
#7 | $13.6M | 88 | -14% | N/A | N/A |
#8 | $15.5M | 100 | 9% | N/A | N/A |
#9 | $19.7M | 127 | 8% | N/A | N/A |
#10 | $21.2M | 137 | -4% | $33.8M | N/A |
What Is SpeeDx Pty Ltd?
Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
keywords:N/A
$33.8M
Total Funding
137
Number of Employees
$21.2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SpeeDx Pty Ltd News
Australia's SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has added saliva to the list of validated samples...
SYDNEY, Australia--(BUSINESS WIRE)--SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have added saliva to the...
MISSISSAUGA, Ontario and EVELEIGH, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. (SpeedDx), a developer of innovative molecular diagnostics solutions, are pleased to announc ...
SpeeDx Pty Ltd, a Sydney, Australia-based developer of innovative clinical diagnostics to support improved patient outcomes, raised $15m in series B equity funding. The round was led by Northpond Ventures. The company intends to use the funds to continue to advance its pipeline. SpeeDx specia ...
SpeeDx Pty. Ltd., a Sydney, Australia-based developer of new molecular diagnostic solutions, raised up to US $10m in additional equity funding. Northpond Ventures made the investment, which follows an original deal of US$5m in April 2019. The company intends to use the funds to expedite intern ...
Other Companies in Eveleigh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $72.7M | 401 | 2% | N/A |
#2 | $139.1M | 412 | 7% | N/A |